Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of "Hold" by Analysts

Key Points

• Teladoc Health has a consensus recommendation of "Hold" from eighteen analysts, with one sell rating, eleven hold ratings, and six buy ratings.
• Institutional investors own 76.82% of Teladoc's stock, with notable increases in holdings from several hedge funds, including a 60.8% stake lift by Cambridge Investment Research Advisors.
• Despite a revenue increase to $631.90 million in the last quarter, Teladoc reported a negative EPS of ($0.19), slightly better than expected, while guiding for a challenging outlook with negative EPS projections for Q3 2025 and FY 2025.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been assigned a consensus recommendation of "Hold" from the eighteen analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $9.7969.

TDOC has been the subject of a number of research reports. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Teladoc Health in a research report on Saturday, September 27th. Evercore ISI upped their target price on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Finally, Mizuho assumed coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price for the company.

Institutional Trading of Teladoc Health

Hedge funds have recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after acquiring an additional 15,030 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares during the last quarter. Wedmont Private Capital raised its position in shares of Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock valued at $117,000 after purchasing an additional 2,715 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Teladoc Health by 22.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after buying an additional 2,662 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in shares of Teladoc Health by 78.8% during the 1st quarter. American Century Companies Inc. now owns 375,050 shares of the health services provider's stock valued at $2,985,000 after buying an additional 165,332 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Stock Up 6.2%

TDOC opened at $9.01 on Friday. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a 50 day moving average price of $7.66 and a 200 day moving average price of $7.60. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The company has a market cap of $1.59 billion, a PE ratio of -7.57 and a beta of 1.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the firm earned ($0.38) earnings per share. Teladoc Health's revenue for the quarter was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Sell-side analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.